InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: None

Friday, 02/03/2017 5:51:28 AM

Friday, February 03, 2017 5:51:28 AM

Post# of 687265
Came across this which I found interesting, scroll down and DCVax is list and not sure what this about but includes a couple of attached documents. Link is at the bottom.

Proposed technology appraisals
These are the topics which the National Institute for Health and Care Excellence has been invited to appraise.

For each proposed appraisal, the table gives the suggested remit, the dates of the consultation on that remit, an e-mail address to send any enquiries to regarding the proposed appraisal, and links to any documents being consulted on in addition to the suggested remit.

DCVax-L for treating newly diagnosed glioblastoma
Suggested remit

To appraise the clinical and cost effectiveness of DCVax-L for newly diagnosed glioblastoma multiforme.


Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

26 January – 23 February 2017


Batch

50


ID number

836


Scoping workshop

No workshop - consultation only

https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/proposed-technology-appraisals#DCVax-L
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News